Kaplan + Sadock's Synopsis of Psychiatry, 11e
1298
Chapter 31: Child Psychiatry
Table 31.18d-2 Pharmacologic Agents for Psychiatric Disorders in Children Adolescents ( continued )
Drug
Indications
Dosage
Adverse Reactions
Antidepressants Tricyclic antidepressants clomipramine (Anafranil)
Major depressive disorder, separation anxiety disorder, bulimia nervosa, enuresis; sometimes used in ADHD, sleepwalking disorder, and sleep terror disorder Clomipramine is effective in childhood OCD and sometimes in PDD OCD, Anxiety Disorders, Depressive disorders Bulimia
eventually combine in one dose, which is usually 50–100 mg before sleep Clomipramine—start at 50 mg per day; can raise to not more than 3 mg/kg per day or 200 mg per day
Dry mouth, constipation, tachycardia, arrhythmia
Selective serotonin reuptake inhibitors — fluoxetine (Prozac), sertraline (Zoloft), fluvoxamine (Luvox), paroxetine (Paxil), citalopram (Celexa) Bupropion (Wellbutrin)
Less than adult dosages
Nausea, headache, nervousness, insomnia, dry mouth, diarrhea, drowsiness, disinhibition
ADHD
Start 50 mg and titrate up to between 100 and 250 mg per day
Disinhibition, insomnia, dry mouth, gastrointestinal problems, tremor, seizures
Anxiolytics Benzodiazepines Clonazepam (Klonopin)
Panic disorder, generalized anxiety disorder Separation anxiety disorder Various anxiety disorders
0.5–2.0 mg per d
Drowsiness, disinhibition
Alprazolam (Xanax) Buspirone (BuSpar)
Up to 1.5 mg per day 15–90 mg per day
Drowsiness, disinhibition Dizziness, upset stomach
a 2
-Adrenergic receptor agonists
Clonidine (Catapres)
ADHD, Tourette’s disorder, aggression
Up to 0.4 mg per day
Bradycardia, arrhythmia, hypertension, withdrawal hypotension Same as with clonidine plus headache, stomachache
Guanfacine (Tenex)
ADHD
0.5–3.0 mg per day
b -Adrenergic receptor antagonist (beta blocker) Propranolol (Inderal)
Explosive aggression
Start at 20–30 mg per day, and titrate
Monitor for bradycardia, hypotension, bronchoconstriction Contraindicated in asthma and diabetes
Other agents Desmopressin (DDAVP)
20–40 m g intranasally
Nocturnal enuresis
Headache, nasal congestion, hyponatremic seizures (rare)
Table by Richard Perry, M.D.
etine is well absorbed after ingestion and reaches its maximal plasma concentration after about 1 to 2 hours. Common side effects of atomoxetine include abdominal discomfort, decreased appetite, dizziness, and irritability. Rarely, minor increases in blood pressure and heart rate have been noted. Atomoxetine is metabolized by the cytochrome P450 (CYP) 2D6 hepatic enzyme system, and a fraction of the population (about 7 per- cent of Caucasians and 2 percent of African Americans) are poor metabolizers, which may increase the plasma half-life by about fivefold. When combined with other medications that inhibit CYP 2D6, such as fluoxetine and paroxetine, diminished metabolism of atomoxetine can occur, and the dose may need to be decreased. Atomoxetine is generally initiated at 0.5 mg/kg
were decreased appetite, headache, insomnia, decreased weight, and irritability. Recent studies support the use of atomoxetine (Strattera), a norepinephrine reuptake inhibitor, as an efficacious nonstimu- lant treatment for ADHD in children and adolescents. Atomox-
Table 31.18d-3 Common Dose-Related Side Effects of Stimulants
Insomnia Decreased appetite Irritability or nervousness Weight loss
Made with FlippingBook